Posterior reversible encephalopathy syndrome in pediatric patients undergoing treatment for hemophagocytic lymphohistiocytosis: Clinical outcomes and putative risk factors

Blood Research

Volumn 48, Issue 4, 2013, Pages 258-265

  Lee, Goni ^a   Lee, Seung Eun ^a   Ryu, Kyung Ha ^a   Yoo, Eun Sun ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Child; Hemophagocytic lymphohistiocytosis; HLH 2004; Posterior reversible encephalopathy syndrome; Reversible; Risk factors

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; ETIRACETAM; ETOPOSIDE; FERRITIN; HYDRALAZINE; MIDAZOLAM; NIFEDIPINE; PHENYTOIN; TACROLIMUS; VALPROIC ACID;

ACUTE DISEASE; ADOLESCENT; ANTICONVULSANT THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW UP; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERTENSION; HYPONATREMIA; IMMUNOSUPPRESSIVE TREATMENT; INDUCTION CHEMOTHERAPY; LONG TERM CARE; MALE; MEDICAL RECORD REVIEW; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SEIZURE;

EID: 84891078831     PISSN: 2287979X     EISSN: 22880011     Source Type: Journal    
DOI: 10.5045/br.2013.48.4.258     Document Type: Article

References (31)

1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
2. Wirrell EC, Hamiwka LD, Hamiwka LA, Grisaru S, Wei X. Acute glomerulonephritis presenting with PRES: a report of 4 cases. Can J Neurol Sci 2007;34:316-21.
3. Thackeray EM, Tielborg MC. Posterior reversible encephalopathy syndrome in a patient with severe preeclampsia. Anesth Analg 2007;105:184-6.
4. El Karoui K, Le Quintrec M, Dekeyser E, et al. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. Nephrol Dial Transplant 2008;23:757-63.
5. Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006;27:2179-90.
6. Fuchigami T, Inamo Y, Hashimoto K, et al. Henoch-schonlein purpura complicated by reversible posterior leukoencephalopathy syndrome. Pediatr Emerg Care 2010;26:583-5.
7. Ozcakar ZB, Ekim M, Fitoz S, et al. Hypertension induced reversible posterior leukoencephalopathy syndrome: a report of two cases. Eur J Pediatr 2004;163:728-30.
8. Endo A, Fuchigami T, Hasegawa M, et al. Posterior reversible encephalopathy syndrome in childhood: report of four cases and review of the literature. Pediatr Emerg Care 2012;28:153-7.
9. Kim SJ, Im SA, Lee JW, et al. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia. Pediatr Neurol 2012;47:436-42.
10. de Laat P, Te Winkel ML, Devos AS, Catsman-Berrevoets CE, Pieters R, van den Heuvel-Eibrink MM. Posterior reversible encephalopathy syndrome in childhood cancer. Ann Oncol 2011;22:472-8.
11. Gumus H, Per H, Kumandas S, Yikilmaz A. Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature. Neurol Sci 2010;31:125-31.
12. Won SC, Kwon SY, Han JW, Choi SY, Lyu CJ. Posterior reversible encephalopathy syndrome in childhood with hematologic/ oncologic diseases. J Pediatr Hematol Oncol 2009;31:505-8.
13. Morris EB, Laningham FH, Sandlund JT, Khan RB. Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 2007;48:152-9.
14. Gupta A, Swaroop C, Rastogi R, Garg R, Bakhshi S. Simultaneous occurrence of posterior reversible leukoencephalopathy syndrome in two cases of childhood acute lymphoblastic leukemia induction chemotherapy. Pediatr Hematol Oncol 2008;25:351-8.
15. Saeed B, Abou-Zor N, Amer Z, Kanani I, Hilal M. Cyclosporin-A induced posterior reversible encephalopathy syndrome. Saudi J Kidney Dis Transpl 2008;19:439-42.
16. Yokobori S, Yokota H, Yamamoto Y. Pediatric posterior reversible leukoencephalopathy syndrome and NSAID-induced acute tubular interstitial nephritis. Pediatr Neurol 2006;34:245-7.
17. Hourani R, Abboud M, Hourani M, Khalifeh H, Muwakkit S. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children. Neuropediatrics 2008;39:46-50.
18. Filipovich AH. Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders. Immunol Allergy Clin North Am 2008;28:293-313.
19. Thompson PA, Allen CE, Horton T, Jones JY, Vinks AA, McClain KL. Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2009;52:621-5.
20. Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31.
21. Henter JI, Nennesmo I. Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J Pediatr 1997;130:358-65.
22. Yakushijin K, Mizuno I, Sada A, et al. Cyclosporin neurotoxicity with Epstein-Barr virus-associated hemophagocytic syndrome. Haematologica 2005;90:ECR11.
23. Bartynski WS, Tan HP, Boardman JF, Shapiro R, Marsh JW. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 2008;29:924-30.
24. Pavlakis SG, Frank Y, Chusid R. Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol 1999;14:277-81.
25. Eguchi K, Kasahara K, Nagashima A, et al. Two cases of malignant hypertension with reversible diffuse leukoencephalopathy exhibiting a reversible nocturnal blood pressure "riser" pattern. Hypertens Res 2002;25:467-73.
26. Norman JK, Parke JT, Wilson DA, McNall-Knapp RY. Reversible posterior leukoencephalopathy syndrome in children undergoing induction therapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2007;49:198-203.
27. Truwit CL, Denaro CP, Lake JR, DeMarco T. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651-9.
28. Irvin W, MacDonald G, Smith JK, Kim WY. Dexamethasoneinduced posterior reversible encephalopathy syndrome. J Clin Oncol 2007;25:2484-6.
29. Torelli GF, Natalino F, Barberi W, et al. Early onset of posterior reversible encephalopathy syndrome (PRES) during Cyclosporine-A infusion. Leuk Res 2011;35:1423-4.
30. Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000;13:313-26.
31. Wong R, Beguelin GZ, de Lima M, et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2003;122:128-34.